^
BIOMARKER:
TMB-L
i
Other names: TMB | Tumor Mutational Burden
Related biomarkers:
TMB-L
Melanoma
trametinib + dabrafenib + PDR001
Sensitive
:
B
TMB-L
CRC
durvalumab + CP-675206
Sensitive
:
C3
TMB-L
Adrenal Cortex Carcinoma
mitotane
Sensitive
:
C3
TMB-L
Malignant Pleural Mesothelioma
PD1 inhibitor
Resistant
:
C3
TMB-L
Malignant Pleural Mesothelioma
PD-L1 inhibitor
Resistant
:
C3
TMB-L
GBM
PD1 inhibitor
Sensitive
:
C3
TMB-L
NSCLC
atezolizumab
Sensitive
:
C3
TMB-L
NSCLC
durvalumab + CP-675206
Resistant
:
C3
TMB-L
Pancreatic Cancer
nivolumab + BMS-986227
Sensitive
:
C3
TMB-L
Lung Cancer
Tyrosine kinase inhibitor
Sensitive
:
C3
TMB-L
Gastric Cancer
Immunotherapy
Resistant
:
C3
TMB-L
Pancreatic Ductal Adenocarcinoma
trametinib + Torin1
Sensitive
:
D
TMB-L
Gastric Cancer
olaparib
Resistant
:
D
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our